Alzheimer’s Drug Discovery Foundation, OnDeckBiotech to Launch Open Access Research Platform

Alzheimer’s Drug Discovery Foundation, OnDeckBiotech to Launch Open Access Research Platform
ADDF ACCESSThe Alzheimer's Drug Discovery Foundation (ADDF) and the Boston-based software company OnDeckBiotech are launching a new open access platform with the purpose of creating an improved way to connect scientists with a virtual network of contract research organizations (CROs), drug development experts, and educational resources. The announcement was made on third day of the ADDF's 15th International Conference on Alzheimer's Drug Discovery
Subscribe or to access all post and page content.